Trial Profile
A Multicenter, Double-Blind, Placebo Controlled Exploratory Study to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Administration of BCT194 in Healthy Volunteers and Multiple Administrations in Patients With Psoriasis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs BCT 194 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 02 Mar 2012 New trial record